申请人:R.J. REYNOLDS TOBACCO COMPANY
公开号:EP0567250A1
公开(公告)日:1993-10-27
Patients suffering from neurodegenerative diseases are treated by administering an effective amount of a pyridylalkylpiperidine compound or a pyridylalkylpyrrolidine compound.
神经退行性疾病患者可通过服用有效量的
吡啶基
哌啶化合物或
吡啶基
吡咯烷化合物进行治疗。